Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts
about
Oncolytic virotherapy using herpes simplex virus: how far have we come?Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyHigh efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsUnlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyGenome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.Designing Herpes Viruses as Oncolytics.Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling PathwayCombined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells.The art of gene therapy for glioma: a review of the challenging road to the bedsideEXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMAOncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyCombinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.Viral therapy of glioblastoma multiforme.Oncolytic herpes viruses, chemotherapeutics, and other cancer drugsTargeting cancer stem cells with oncolytic virusHSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapyRetinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide.N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapyOncolytic viral therapy: targeting cancer stem cellsBlockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma.Oncolytic virus as a cancer stem cell killer: progress and challenges.Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine.Combination strategies enhance oncolytic virotherapy.
P2860
Q26862461-810860EA-307E-4918-8677-F663CC0952C7Q26998111-FEB3BE3E-9A43-45FF-ACBE-F4D0185A1B7EQ33828697-D8C30AC9-AA62-4E66-9C6F-4B9C5CCA82A6Q34715771-235ED163-BE4A-4204-876A-7C87527412D7Q35545752-3B939089-4198-41A0-9CBA-CB6C84D3E4A0Q35657822-53B50CB3-842D-4C42-9DC3-2E71C9D02737Q35740932-C29D38E3-C805-495E-A71E-CCD9F8F5ABE8Q36142487-C39E48D5-162C-40FC-9043-C53BB4563884Q36247757-47973413-6DD8-4132-AF58-0F19E0673590Q36321693-6D58AE9E-A8D8-48A0-8399-3CAE96028570Q36527593-B32ABD1E-B4D2-4F42-BF95-3469FC57EC5AQ36549443-1380C6FB-5086-4E57-9DDA-A94EFF163495Q36634430-A175FC18-450A-4241-A759-F94369050EA9Q36644898-F3744419-F585-4A98-95F4-2FDE920CC661Q36849213-275CC1BD-0E62-4CE7-9780-16500207AA0EQ36947035-60129783-1704-4D9D-B6F0-162E6C8CF5E1Q37031664-E3913D6C-CBCF-4DEB-89C0-7D266D2D68AFQ37031896-6AC56EBD-8AF1-47FE-81B2-55CFDD5C38A1Q37044088-B596E7C0-ED17-4A8C-B20F-974F9008D5C3Q37104963-9BF6EC19-A242-42E4-BED3-C7A60B7697D9Q37148255-40B6DC6D-9243-4F93-BEF6-93016A2F9ABAQ37316856-DD978B41-2BAE-4547-B56A-88A95B876C0DQ38212255-16FF2999-4E1B-48E6-AB8A-9AAB53FFDC75Q38400073-2EC3FB36-EEB4-4F09-871D-46171038A2E2Q38799515-E85282F8-F2EE-40E0-A42A-0B38A3C46D80Q38881477-63ADF21E-51F0-4EDC-9F54-789C0A3044A7Q38934256-4C9A99C4-DDF2-4332-A5D2-0EF8FFC6AFFAQ39205115-17377F92-EDC3-4706-B962-E783B2F027F9Q39366720-64D7BFCE-EF11-43F3-9B29-D940A7B88BB4Q39380065-493E0F27-C978-41D0-9E1A-149A82DF4F44Q40162348-97BA4C48-69BD-4EA0-B5EA-2D9B4ED297E8Q42338756-FE907AE7-648F-4849-8526-85454B2977E6
P2860
Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enhanced antitumor efficacy of ...... oblastoma stem cell xenografts
@en
Enhanced antitumor efficacy of ...... blastoma stem cell xenografts.
@nl
type
label
Enhanced antitumor efficacy of ...... oblastoma stem cell xenografts
@en
Enhanced antitumor efficacy of ...... blastoma stem cell xenografts.
@nl
prefLabel
Enhanced antitumor efficacy of ...... oblastoma stem cell xenografts
@en
Enhanced antitumor efficacy of ...... blastoma stem cell xenografts.
@nl
P2093
P2860
P1476
Enhanced antitumor efficacy of ...... oblastoma stem cell xenografts
@en
P2093
Brent Passer
Geon Woo Kim
Hiroaki Wakimoto
Ryuichi Kanai
Tooba A Cheema
P2860
P304
P356
10.1158/1078-0432.CCR-11-1762
P407
P577
2011-10-05T00:00:00Z